More Clinical Articles

Clinical

India Touts A Safe Haven For Investors But Says No To Big Pharma

Louise Kelly, (Apr 2, 2013)

India’s Supreme Court rejected Novartis’ patent application for the cancer drug Glivec yesterday. A victory for the Indian drug industry, but the result may have repercussions on India’s attempts to attract foreign investment
Clinical

Should I Stay Or Should I Go?

Louise Kelly, (Mar 28, 2013)

Global pharma firms, dismayed by recent intellectual property decisions in India, are awaiting a landmark court ruling next week that could have severe implications on their ability to sell branded medicines in the country.
Clinical

Qualified Sites the Biggest Issue for Rare Disease Trials

Zuzanna Fimińska, (Mar 26, 2013)

Setting up the right sites, in addition to recruitment and patient retention, makes trials of treatments for rare diseases challenging, a survey of clinical development decision-makers, conducted by Premier Research, has revealed.
Clinical

UK Patients Begin Personalised Cancer Treatment after Gene Test

Anonymous, (Mar 25, 2013)

Around 1,000 UK cancer patients will undergo a multi-gene cancer test, for the first time, which will enable the development of personalised cancer therapies.
Clinical

Taxpayers To Profit From Sales Of New Drugs

Zuzanna Fimińska, (Mar 22, 2013)

While Pfizer is getting ready to launch a potential blockbuster treatment for arthritis, US lawmakers demand a review of federal policies that would prevent businesses from profiting from government-funded research without delivering benefits to taxpayers.
Clinical

FDA vs. State Courts: Supreme Court Hears Generic Liability Suit

Ben Steele, (Mar 20, 2013)

The Supreme Court heard a case on Tuesday which will decide whether generics firms can be held liable and sued over alleged design flaws in their medications.
Clinical

New EU Legislation Needed To Investigate Long-Term Safety Of Chronic Treatment

Anonymous, (Mar 20, 2013)

Current legislation is insufficient to evaluate the long-term safety and efficacy of chronic drugs for patients before regulatory approval.
Clinical

MPs Hear Why Clinical Trials Are Off-Putting To Researchers And Patients

Zuzanna Fimińska, (Mar 19, 2013)

The clinical trials systems and the governing regulations must change in order for the UK to remain an attractive site for conducting research, MPs heard from expert witnesses during an evidence hearing held last week before the House of Commons Science and Technology Committee.
Clinical

AstraZeneca Reduces Workforce And Relocates Global Corporate Headquarters To UK

Lucy Brake, (Mar 19, 2013)

AstraZeneca announced yesterday plans to reorganise its strategic research and development centres as it aims to establish itself as a global leader in biopharmaceutical innovation.
Clinical

Prevent Diabetes Through A Community Rather Than Clinical Approach

Anonymous, (Mar 18, 2013)

Community programmes could be equally effective in the long term to clinical iniatives in preventing type II diabetes, a US study has recently highlighted

Pages